Patients researching ALUNBRIG price are often looking for ways to better manage out-of-pocket expenses. ProviderX helps eligible patients coordinate access to ALUNBRIG (brigatinib) through licensed pharmacies in Tijuana, Mexico, using a structured cross-border prescription program.
Based on recent cross-border quotes, many patients report meaningful ALUNBRIG price savings compared to typical U.S. cash pharmacy prices. Savings vary depending on dosage, availability, and pharmacy partner.
Savings are estimates only. Final costs depend on dosage, pharmacy, and availability. ProviderX does not prescribe medications, operate a pharmacy, or ship medications into the United States.
*Example medication packaging from licensed providers in Tijuana.
ALUNBRIG is a specialty prescription medication, which often requires additional coordination compared to standard prescriptions. Below is a clear, step-by-step overview of how access is coordinated through ProviderX.
Upload your valid U.S. prescription for ALUNBRIG through our HIPAA-secure form. We only work with prescriptions issued by licensed U.S. healthcare providers.
Once eligibility is confirmed, our team coordinates the logistics required for your visit to Tijuana and prepares the medication pickup with licensed pharmacy partners.
You will visit licensed pharmacies in Tijuana where ALUNBRIG is prepared and made available in accordance with international regulatory standards.
Pick up your medication in person and return home the same day, with guidance and coordination support throughout the process.
What ALUNBRIG is
ALUNBRIG (brigatinib) is a prescription medication classified as a tyrosine kinase inhibitor (TKI). It is manufactured by Takeda and is available only with a valid prescription.
Approved medical uses (factual)
According to official prescribing information, ALUNBRIG is approved for use in adults with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). This includes use in patients whose disease has progressed on or who are intolerant to prior ALK inhibitor therapy, as well as use in certain first-line treatment settings, depending on regulatory approval and labeling.
Important medical notice
This information is provided for educational purposes only. ProviderX does not provide medical care, prescribe medications, or offer treatment recommendations. Decisions regarding ALUNBRIG should be made by a licensed healthcare provider familiar with the patient’s medical history.
Nisl adipiscing leo id magna egestas eget dapibus enim et. Massa non scelerisque porttitor.
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
R
S
T
V
X
